Found: 62
Select item for more details and to access through your institution.
CYP2B6 and ABCB1 genotypes predict methadone plasma exposure among patients on maintenance therapy against opioid addictions in Tanzania.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 11, p. 2823, doi. 10.1111/bcp.16173
- By:
- Publication type:
- Article
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2012, v. 38, n. 3, p. 426, doi. 10.1093/schbul/sbq086
- By:
- Publication type:
- Article
Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia -- significance for activation of the kynurenine pathway.
- Published in:
- Journal of Psychiatry & Neuroscience, 2015, v. 40, n. 2, p. 126, doi. 10.1503/jpn.140126
- By:
- Publication type:
- Article
A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 1, p. 103, doi. 10.1016/j.clpt.2005.10.002
- By:
- Publication type:
- Article
Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 6, p. 702, doi. 10.1067/mcp.2002.129321
- By:
- Publication type:
- Article
Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19)<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 71, n. 3, p. 141, doi. 10.1067/mcp.2002.121788
- By:
- Publication type:
- Article
Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 71, n. 1, p. 89, doi. 10.1067/mcp.2002.121216
- By:
- Publication type:
- Article
CYP2D6 polymorphism is not crucial for the disposition of selegiline<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 4, p. 402, doi. 10.1016/S0009-9236(98)90071-6
- By:
- Publication type:
- Article
Pharmacokinetics of nortriptyline and its 10-hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 4, p. 384, doi. 10.1016/S0009-9236(98)90069-8
- By:
- Publication type:
- Article
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 4, p. 391, doi. 10.1016/S0009-9236(98)90070-4
- By:
- Publication type:
- Article
10-hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 63, n. 4, p. 444, doi. 10.1016/S0009-9236(98)90040-6
- By:
- Publication type:
- Article
Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 60, n. 2, p. 183, doi. 10.1016/S0009-9236(96)90134-4
- By:
- Publication type:
- Article
The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 4, p. 423, doi. 10.1016/S0009-9236(96)90111-3
- By:
- Publication type:
- Article
Stereoselective disposition of mianserin is related to debrisoquin hydroxylation polymorphism.
- Published in:
- Clinical Pharmacology & Therapeutics, 1994, v. 56, n. 2, p. 176, doi. 10.1038/clpt.1994.121
- By:
- Publication type:
- Article
Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents.
- Published in:
- Clinical Pharmacology & Therapeutics, 1993, v. 54, n. 6, p. 606, doi. 10.1038/clpt.1993.197
- By:
- Publication type:
- Article
Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population.
- Published in:
- Clinical Pharmacology & Therapeutics, 1992, v. 51, n. 1, p. 12, doi. 10.1038/clpt.1992.2
- By:
- Publication type:
- Article
Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in luman beings.
- Published in:
- Clinical Pharmacology & Therapeutics, 1989, v. 46, n. 1, p. 78, doi. 10.1038/clpt.1989.109
- By:
- Publication type:
- Article
Stereoselective disposition of racemic E-10-hydroxynortriptyline in human beings.
- Published in:
- Clinical Pharmacology & Therapeutics, 1989, v. 45, n. 6, p. 650, doi. 10.1038/clpt.1989.86
- By:
- Publication type:
- Article
Cytochrome P450 2J2*7 Single-nucleotide Polymorphism and Nocturnal Hypertension in an Elderly Turkish Population.
- Published in:
- Gazi Medical Journal, 2024, v. 35, n. 3, p. 325, doi. 10.12996/gmj.2024.4075
- By:
- Publication type:
- Article
Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Recruitment to doping and help-seeking behavior of eight female AAS users.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk.
- Published in:
- Carcinogenesis, 2002, v. 23, n. 4, p. 665, doi. 10.1093/carcin/23.4.665
- By:
- Publication type:
- Article
Adverse Metabolic Effects Associated with Atypical Antipsychotics: Literature Review and Clinical Implications.
- Published in:
- Drugs, 2004, v. 64, n. 7, p. 701, doi. 10.2165/00003495-200464070-00003
- By:
- Publication type:
- Article
Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 2, p. 229, doi. 10.1007/s00228-019-02787-x
- By:
- Publication type:
- Article
Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
- Published in:
- Psychopharmacology, 2007, v. 190, n. 4, p. 479, doi. 10.1007/s00213-006-0622-x
- By:
- Publication type:
- Article
Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 67, doi. 10.1007/s00213-002-1059-5
- By:
- Publication type:
- Article
Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone.
- Published in:
- Psychopharmacology, 1999, v. 147, n. 3, p. 300, doi. 10.1007/s002130051171
- By:
- Publication type:
- Article
Tribute to Folke Sjöqvist, a Pioneer in Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 6, p. 1127, doi. 10.1002/cpt.1935
- By:
- Publication type:
- Article
Clinical pharmacology in Stockholm 50 years—report from the jubilee symposium.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
CYP2C19* 17 affects R-warfarin plasma clearance and warfarin INR/dose ratio in patients on stable warfarin maintenance therapy.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 4, p. 433, doi. 10.1007/s00228-015-1812-4
- By:
- Publication type:
- Article
Statin-induced muscle toxicity and susceptibility to malignant hyperthermia and other muscle diseases: a population-based case-control study including 1st and 2nd degree relatives.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 1, p. 117, doi. 10.1007/s00228-014-1776-9
- By:
- Publication type:
- Article
Therapeutic drug monitoring for tomorrow.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, p. 25, doi. 10.1007/s00228-013-1504-x
- By:
- Publication type:
- Article
Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 12, p. 1223, doi. 10.1007/s00228-011-1078-4
- By:
- Publication type:
- Article
Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment?
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 1, p. 47, doi. 10.1007/s00228-010-0883-5
- By:
- Publication type:
- Article
Further evidence for the association between 5-HT<sub>2C</sub> receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 5, p. 477, doi. 10.1007/s00228-007-0450-x
- By:
- Publication type:
- Article
Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer’s disease patients.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 9, p. 721, doi. 10.1007/s00228-006-0168-1
- By:
- Publication type:
- Article
CYP2C9 genetic variants and losartan oxidation in a Turkish population.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 5, p. 337, doi. 10.1007/s00228-004-0785-5
- By:
- Publication type:
- Article
Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 5/6, p. 401, doi. 10.1007/s00228-003-0627-x
- By:
- Publication type:
- Article
CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 3, p. 221, doi. 10.1007/s00228-003-0588-0
- By:
- Publication type:
- Article
Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 2, p. 103, doi. 10.1007/s00228-003-0590-6
- By:
- Publication type:
- Article
Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 1, p. 45, doi. 10.1007/s00228-003-0576-4
- By:
- Publication type:
- Article
The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro.
- Published in:
- European Journal of Clinical Pharmacology, 2001, v. 57, n. 10, p. 729, doi. 10.1007/s00228-001-0376-7
- By:
- Publication type:
- Article
Influence of CYP2C9, 2C19 and 2D6 Genetic Polymorphisms on the Steady-State Plasma Concentrations of the Enantiomers of Fluoxetine and Norfluoxetine.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2005, v. 97, n. 5, p. 296, doi. 10.1111/j.1742-7843.2005.pto_194.x
- By:
- Publication type:
- Article
CYP2D6-inhibiting drugs and risk of fall injuries after newly initiated antidepressant and antipsychotic therapy in a Swedish, register-based case-crossover study.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85022-x
- By:
- Publication type:
- Article
Intra-individual variability in urinary losartan oxidation ratio, an in vivo marker of CYP2C9activity.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 54, n. 2, p. 183, doi. 10.1046/j.1365-2125.2002.01646.x
- By:
- Publication type:
- Article
Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 111, doi. 10.1046/j.0306-5251.2001.01548.x
- By:
- Publication type:
- Article
Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 52, n. 4, p. 447, doi. 10.1046/j.0306-5251.2001.01460.x
- By:
- Publication type:
- Article
Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 52, n. 3, p. 265, doi. 10.1046/j.0306-5251.2001.01437.x
- By:
- Publication type:
- Article
Lack of effect of chloroquine on the debrisoquine (CYP2D6) and S-mephenytoin (CYP2C19) hydroxylation phenotypes.
- Published in:
- British Journal of Clinical Pharmacology, 1996, v. 41, n. 4, p. 344, doi. 10.1046/j.1365-2125.1996.30713.x
- By:
- Publication type:
- Article